156 results on '"Latteri F"'
Search Results
2. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
3. Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study
4. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: A prospective study
5. DNA Ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study
6. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems
7. Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dellʼItalia Meridionale) prospective study
8. Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dellʼItalia Meridionale) prospective study
9. Effect of acetyl-l-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle
10. Activity of a specific inhibitor, gefitinib (Iressa™, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
11. ASSESSMENT OF MINIMAL RESIDUAL DISEASE (MRD) BY DETECTION OF SYT-SSX FUSION TRANSCRIPT (SFT) IN PERIPHERAL BLOOD (PB) OF PATIENTS WITH SYNOVIAL SARCOMA
12. Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide
13. Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study
14. Efficacy and safety of pangenotypic DAAs for chronic HCV infection: real-world data from the RESIST-HCV cohort
15. SUPERIORITY OF THREE-WEEK VS. FOUR-WEEK SCHEDULE OF CISPLATIN (CDDP) AND GEMCITABINE (GEM): RESULTS OF A RANDOMIZED PHASE II STUDY.
16. Surgical management of iatrogenic bile duct injuries
17. Intensified CHOP regimen in aggressive lymphomas:maximal dose intensity and dose density of doxorubicin and cyclophosphamide
18. Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study
19. Dose-escalation of CHOP in non-Hodgkin's lymphoma
20. Usefulness of 18FDG-positron emission tomography for early prediction of response in non-small cell lung cancer (NSCLC) patients treated with erlotinib: results of a pilot study
21. Relationship between the efficiency of muscular work during jumping and the energetics of running
22. The influence of extra load on the mechanical behavior of skeletal muscle
23. Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry
24. Non-small-cell lung cancer patients unsuitable for first-line chemotherapy: A new category of patients for clinical studies?
25. Letter to the Editor (A simple technique of laparoscopic full-thickness anterior abdominal repair of retrosternal (Morgagni) hernias)
26. Cystic lymphangioma of the pancreas – a rare case of gastro-intestinal bleeding
27. A MYSTERIOUS EPILEPSY TREATED SURGICALLY
28. Peritonectomy and intraoperative peritoneal chemo-hyperthermic perfusion (ipchp) for peritoneal carcinomatosis. Preliminary results
29. Hepatic resection of a liver metastases using tissuelink monopolar floating ball® device
30. The psychological request of the patient, justify the surgery for hepatic hemangioma?
31. Efficacy and safety of elective laparoscopic cholecystectomy in elderly: a case controlled comparison with the open approach
32. Hepatic resection, radio interstitial thermal ablation (RITA) and intraperitoneal hypertermic chemotherapy (IPHC) for liver and peritoneal metastases from colorectal cancer. Case report
33. Biliary carcinoembrionic antigen (B-CEA) as a predictive value for liver metastases from colorectal cancer
34. Hepatic resection, for metastatic tumors from noncolorectal noneuroendocrine carcinoma. Personal experience
35. Hepatic resections, radio interstitial thermal ablation (RITA) and intraperitoneal hyperthermic chemotherapy(IPHC) for liver and peritoneal metastases from colorectal cancer
36. Totally implantable venous access device (TIVD) utilization: Five years experience
37. Catheter migration of a totally implantable venous system. A rare mechanical complication
38. Catheter migration of a totally implantable venous device. A rare mechanical complication. [Migrazione del catetere di un sistema totalmente impiantabile. Una rara complicanza meccanica]
39. The management of hepatic trauma: is non-operative treatment the first choice?
40. A new simple laparoscopic extracorporeal technique for the repair of a Morgagni diphragmatic hernia.'
41. F56 - Concomitantly epirubicin and trastuzumab (the Buzdar Regimen) as neo-adjuvant chemotherapy in HER2-overexpressed early breast cancer: a real-life, retrospective, mono-institutional experience
42. F49 - Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her2 positive metastatic breast cancer (mBC)
43. Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer.
44. Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).
45. Effect of acetyl- l-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle.
46. Survival of unresectable hepatocellular carcinoma: A meta-analysis of the control arms of 28 randomized trials
47. Non-small-cell lung cancer patients unsuitable for first-line chemotherapy: a new category of patients for clinical studies?
48. Short-term prophylaxis in colorectal surgery: aztreonam plus clindamycin versus gentamicin plus clindamicyn
49. Possible factors of failure in the transplantation of the islands of Langerhans
50. Splenic trauma and overwhelming postsplenectomy infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.